Metformin improves cancer outcomes

Metformin (Glucophage) is an antihyperglycemic agent that lowers hepatic glucose production, improves peripheral glucose uptake and utilization, and does not cause increased insulin secretion. In fact, “with metformin therapy, insulin secretion remains unchanged while fasting insulin levels and day-long plasma insulin response may actually decrease.” These properties have spawned a great deal of interest in […]